Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.
2024

Is R-MDMA a Safer Version of MDMA?

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): Bedi Gillinder

Primary Institution: Centre for Youth Mental Health, University of Melbourne, and Orygen, Melbourne, Australia

Hypothesis

S-MDMA will produce greater subjective stimulation than R-MDMA, and that R-MDMA will produce greater psychedelic-like effects relative to S-MDMA.

Conclusion

The study suggests that R-MDMA may not be safer than racemic or S-MDMA for clinical use.

Supporting Evidence

  • S-MDMA increased subjective ratings of feeling stimulated relative to both doses of R-MDMA.
  • R-MDMA did not produce stronger psychedelic-like effects than S-MDMA or the racemic compound.
  • All active conditions caused similar transient adverse effects during the sessions.

Takeaway

This study looked at whether a different version of MDMA, called R-MDMA, is safer than the regular MDMA. It found that R-MDMA might not be safer after all.

Methodology

A double-blind, placebo controlled, cross-over design was used to compare the effects of R-MDMA, S-MDMA, racemic MDMA, and placebo.

Potential Biases

The lack of weight-based dosing may introduce bias in the effects observed between male and female participants.

Limitations

The study had limitations including potential dose inequivalence and lack of weight-based dosing which may affect the results.

Participant Demographics

Participants were 24 healthy adults with equal representation of women and men.

Digital Object Identifier (DOI)

10.1038/s41386-024-02009-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication